NQO1 stabilizes p53 through a distinct pathway
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Wild-type p53 is a tumor-suppressor gene that encodes a short-lived protein that, upon accumulation, induces growth arrest or apoptosis. Accumulation of p53 occurs mainly by posttranslational events that inhibit its proteosomal degradation. We have reported previously that inhibition of NAD(P)H: quinone oxidoreductase 1 (NQO1) activity by dicoumarol induces degradation of p53, indicating that NQO1 plays a role in p53 stabilization. We now have found that wild-type NQO1, but not the inactive polymorphic NQO1, can stabilize endogenous as well as transfected wild-type p53. NQO1-mediated p53 stabilization was especially prominent under induction of oxidative stress. NQO1 also partially inhibited p53 degradation mediated by the human papilloma virus E6 protein, but not when mediated by Mdm-2. Inhibitors of heat shock protein 90 (hsp90), radicicol and geldanamycin, induced degradation of p53 and suppressed p53-induced apoptosis in normal thymocytes and myeloid leukemic cells. Differences in the effectiveness of dicoumarol and hsp90 inhibitors to induce p53 degradation and suppress apoptosis in these cell types indicate that NQO1 and hsp90 stabilize p53 through different mechanisms. Our results indicate that NQO1 has a distinct role in the regulation of p53 stability, especially in response to oxidative stress. The present data on the genetic and pharmacologic regulation of the level of p53 have clinical implications for tumor development and therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Knockdown of other previously characterized ROS regulators, including positive regulators such as PARP138, SAT139 and NOX540 and negative regulators such as PTEN41 and FH42,43 showed the expected effects on ROS and/or peroxidized lipid levels in our screens (Fig. 2d).”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [39]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Ko, L. J., & Prives, C. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,344
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Self-citationThe p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420
mdm2 expression is induced by wild type p53 activity.
Barak, Y., Juven, T., Haffner, R., & Oren, M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05678.x · Cited by 1,290
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280
UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.
Maltzman, W., & Czyzyk, L. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1689 · Cited by 893
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Mapping of the p53 and mdm-2 interaction domains.
Chen, J., Marechal, V, & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689
NPAT links cyclin E–Cdk2 to the regulation of replication-dependent histone gene transcription
Zhao, J., Kennedy, B. K., Lawrence, B. D., Barbie, D. A., Matera, A. G., Fletcher, J. A., & Harlow, E. (2000) · Genes & Development · doi:10.1101/gad.827700 · Cited by 665
Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 634
Regulation of the p53 Tumor Suppressor Protein
Oren, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36031 · Cited by 564
Pandey, P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4310 · Cited by 556
Hwang, P. M., Bunz, F., Yu, J., Rago, C., Chan, T. A., Murphy, M. P., Kelso, G. F., Smith, R. A. J., Kinzler, K. W., & Vogelstein, B. (2001) · Nature Medicine · doi:10.1038/nm1001-1111 · Cited by 422
Barak, Y., Gottlieb, E., Juven-Gershon, T., & Oren, M. (1994) · Genes & Development · doi:10.1101/gad.8.15.1739 · Cited by 328
Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1
Asher, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.021558898 · Cited by 317
Self-citationp53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding
Midgley, C. A., & Lane, D. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201459 · Cited by 311
Lotem, J., & Sachs, L. (1993) · Blood · doi:10.1182/blood.v82.4.1092.1092 · Cited by 301
Self-citationDinkova-Kostova, A. T., & Talalay, P. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00300-2 · Cited by 258
Transcriptional Activation of the Human Glutathione Peroxidase Promoter by p53
Tan, M., Li, S., Swaroop, M., Guan, K., Oberley, L. W., & Sun, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.12061 · Cited by 253
Wiemels, J. L., Pagnamenta, A. T., Taylor, G. M., Eden, O. B., Alexander, F. E., & Greaves, M. F. (1999) · PubMed · Cited by 239
Chang, N.-S., Pratt, N., Heath, J., Schultz, L., Sleve, D., Carey, G. B., & Zevotek, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007140200 · Cited by 221
Siegel, D., Anwar, A., Winski, S. L., Kepa, J. K., Zolman, K. L., & Ross, D. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12836-2 · Cited by 207
Whitesell, L., Sutphin, P. D., Pulcini, E. J., Martinez, J. D., & Cook, P. H. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1517 · Cited by 206
Geldanamycin selectively destabilizes and conformationally alters mutated p53.
Blagosklonny, M. V., Toretsky, J. A., & Neckers, L. (1995) · PubMed · Cited by 202
Inhibition of MDM2 by hsp90 Contributes to Mutant p53 Stabilization
Peng, Y., Chen, L., Li, C., Lu, W., & Chen, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102817200 · Cited by 183
Reciprocal down-regulation of p53 and SOD2 gene expression-implication in p53 mediated apoptosis
Drane, P., Bravard, A., Bouvard, V., & May, E. (2001) · Oncogene · doi:10.1038/sj.onc.1204101 · Cited by 180
King, F. W. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6297 · Cited by 167
Moran, J. L., Siegel, D., & Ross, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8150 · Cited by 153
Smith, M. T., Wang, Y., Kane, E. V., Rollinson, S. J., Wiemels, J. L., Roman, E., Roddam, P. L., Cartwright, R. A., & Morgan, G. J. (2001) · Blood · doi:10.1182/blood.v97.5.1422 · Cited by 145
Analysis of human p53 proteins and mRNA levels in normal and transformed cells
MATLASHEWSKI, G., BANKS, L., PIM, D., & CRAWFORD, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09449.x · Cited by 139
Lotem, J., Peled-Kamar, M., Groner, Y., & Sachs, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9166 · Cited by 137
Self-citationLong, D. J., Waikel, R. L., Wang, X., Roop, D. R., & Jaiswal, A. K. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.15.1166 · Cited by 126
Muslin, A. J., MacNicol, A. M., & Williams, L. T. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4197 · Cited by 120
Nagata, Y., Anan, T., Yoshida, T., Mizukami, T., Taya, Y., Fujiwara, T., Kato, H., Saya, H., & Nakao, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202978 · Cited by 108
Genetic dissection of the control of normal differentiation in myeloid leukemic cells
Lotem, J., & Sachs, L. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5554 · Cited by 92
Self-citationLafuente, M. J., Casterad, X., Trías, M., Ascaso, C., Molina, R., Ballesta, A. M., Zheng, S. Y., Wiencke, J. K., & Lafuente, A. (2000) · Carcinogenesis · doi:10.1093/carcin/21.10.1813 · Cited by 92
Ross, D., Traver, R. D., Siegel, D. M., KUEHL, B. L., Misra, V., & Rauth, A. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.477 · Cited by 68
Lewis, S. J., Cherry, N., Niven, R. M., Barber, P. V., & Povey, A. C. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00243-4 · Cited by 57
Cytokines as suppressors of apoptosis
Lotem, J., & Sachs, L. (1999) · APOPTOSIS · doi:10.1023/a:1009614723237 · Cited by 48
Self-citationGeldanamycin Prevents Nuclear Translocation of Mutant p53
Dasgupta, G., & Momand, J. A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3766 · Cited by 48
Research works printed but not linked: 6
- 10.1128/mcb.4.9.1689-1694.1984 · DOI · Paper page
- M V Blagosklonny, J Toretsky, L Neckers Oncogene 11, 933–939 (1995).
- 10.1073/pnas.98.3.1188 · doi:10.1073/pnas.98.3.1188 · Paper page
- J L Wiemels, A Pagnamenta, G M Taylor, O B Eden, F E Alexander, M F Greaves Cancer Res 59, 4095–4099 (1999).
- J Chen, V Marechal, A J Levine Mol Cell Biol 13, 4197–4114 (1993).
- 10.1124/mol.59.2.263 · doi:10.1124/mol.59.2.263 · Paper page
Cited by
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation
Brooks, C. L., & Gu, W. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00003-6 · Cited by 742
“Reduced nicotinamide adenine dinucleotide (NADH) quinone oxidoreductase 1 (NQO1) stabilizes p53 by an Mdm2- and ubiquitinindependent mechanism [40–42].”
BackgroundDinkova-Kostova, A. T., & Talalay, P. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.03.019 · Cited by 718
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2020) · doi:10.1101/2020.06.27.175679 · Cited by 414
Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis
Tian, R., Abarientos, A., Hong, J., Hashemi, S. H., Yan, R., Dräger, N., Leng, K., Nalls, M. A., Singleton, A. B., Xu, K., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00862-0 · Cited by 414
Metadata
- Authors
- Asher, G., Lotem, J., Kama, R., Sachs, L., & Shaul, Y.
- Affiliations
- Weizmann Institute of Science (IL)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-02-26
- Volume
- 99
- Issue
- 5
- Pages
- 3099-3104
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC122479
- OpenAlex
- W2024568523
- Cited by
- 291
- References
- 49
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 11 · 2023: 9 · 2022: 9 · 2021: 5 · 2020: 8 · 2019: 12 · 2018: 11 · 2017: 17 · 2016: 9 · 2015: 7 · 2014: 14 · 2013: 8 · 2012: 18
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Keywords
- NQO1, p53 stabilization, p53 degradation, oxidative stress, Hsp90 inhibitors, dicumarol, E6 oncoprotein, MDM2, apoptosis, tumor suppressor, NQO1 polymorphism, thymocytes, myeloid leukemia cells
- MeSH terms
- Animals, Humans, Mice, Inbred BALB C, Nuclear Proteins, Proto-Oncogene Proteins, Quinone Reductases, Tumor Cells, Cultured, Signal Transduction, Tumor Suppressor Protein p53, NAD(P)H Dehydrogenase (Quinone), Oxidative Stress, HSP90 Heat-Shock Proteins, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.